Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal versus intramuscular H5N8 influenza vaccine study in adults aged 40 to 80 years
NL-OMON61807Phase 2Not yet recruiting
- Sponsor
- University of Antwerp
- Start
- Oct 2026
- Countries
- 1
01
Overview
Phase 2 trial in Avian Influenza (AI) (2 arms), sponsored by University of Antwerp. Primary endpoints: Hemagglutination inhibition antibody geometric mean titer ratio and Hemagglutination inhibition seroconversion rate. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NL-OMON61807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61807.